Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study.

Front Med (Lausanne) · 2025 · PMC12832974 · PMID 41601728

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Regarding the predictors of achieving SU levels below 5 mg/dL, only age (OR 1.066, 95% CI 0.993–1.144; p = 0.079) and BMI (OR 0.858; 95% CI 0.724–1.018; p = 0.080) showed a trend towards a significant association with the endpoint when considered as continuous variables in the bivariate model.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.